Published in Medical Verdicts and Law Weekly, June 7th, 2007
Study 1: A new study, "Acute and chronic effect of teriparatide on glucose metabolism in women with established osteoporosis," is now available. According to a study from Thessaloniki, Greece, "There is indirect evidence of unfavorable effects of parathyroid hormone (PTH) on glucose metabolism. Teriparatide (recombinant human PTH 1-34-TPTD) has recently been available for the treatment of osteoporosis."
"The aim of this prospective study was to evaluate the acute and chronic effect of TPTD on blood glucose and insulin levels in women...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.